Lisa A. Beck, MD - Integrating the Latest Evidence Into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe Atopic Dermatitis

Go online to PeerView.com/RSD860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit. In this activity, an expert dermatologist discusses the
latest evidence from the 30th European Academy of Dermatology and
Venereology Congress for current and emerging targeted biologic
therapies for moderate to severe atopic dermatitis in adults and
children. Upon completion of this accredited CE activity,
participants should be better able to: Interpret recent
developments in clinical research and treatment guidelines
regarding the management of pediatric and adult patients with
moderate to severe atopic dermatitis, Apply the latest clinical
evidence on approved and emerging biologic therapies into
personalized treatment plans for pediatric and adult patients with
moderate to severe atopic dermatitis.